Syntal Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-13,589
| Closed | -$451K | – | 76 |
|
2023
Q3 | $451K | Sell |
13,589
-15,195
| -53% | -$504K | 0.35% | 80 |
|
2023
Q2 | $1.06M | Sell |
28,784
-514
| -2% | -$18.9K | 0.42% | 73 |
|
2023
Q1 | $1.2M | Buy |
29,298
+4,010
| +16% | +$164K | 0.44% | 75 |
|
2022
Q4 | $1.3M | Buy |
25,288
+1,123
| +5% | +$57.5K | 0.51% | 44 |
|
2022
Q3 | $1.06M | Buy |
+24,165
| New | +$1.06M | 0.43% | 47 |
|
2022
Q1 | – | Sell |
-20,932
| Closed | -$1.24M | – | 104 |
|
2021
Q4 | $1.24M | Sell |
20,932
-13
| -0.1% | -$768 | 0.53% | 47 |
|
2021
Q3 | $900K | Sell |
20,945
-6,522
| -24% | -$280K | 0.31% | 75 |
|
2021
Q2 | $1.08M | Buy |
27,467
+15,991
| +139% | +$626K | 0.38% | 81 |
|
2021
Q1 | $415K | Buy |
+11,476
| New | +$415K | 0.16% | 96 |
|
2019
Q4 | – | Sell |
-217,214
| Closed | -$7.4M | – | 178 |
|
2019
Q3 | $7.4M | Sell |
217,214
-6,618
| -3% | -$226K | 1.92% | 11 |
|
2019
Q2 | $9.2M | Buy |
+223,832
| New | +$9.2M | 1.98% | 10 |
|
2015
Q4 | – | Sell |
-816
| Closed | -$24K | – | 124 |
|
2015
Q3 | $24K | Buy |
816
+2
| +0.2% | +$59 | 0.03% | 105 |
|
2015
Q2 | $25 | Buy |
814
+1
| +0.1% | – | 0.02% | 125 |
|
2015
Q1 | $26K | Buy |
813
+2
| +0.2% | +$64 | 0.03% | 133 |
|
2014
Q4 | $23K | Buy |
811
+2
| +0.2% | +$57 | 0.01% | 149 |
|
2014
Q3 | $22K | Buy |
809
+177
| +28% | +$4.81K | 0.01% | 158 |
|
2014
Q2 | $17K | Sell |
632
-11,004
| -95% | -$296K | 0.01% | 178 |
|
2014
Q1 | $354 | Buy |
+11,636
| New | +$354 | 0.21% | 40 |
|